摘要
目的基于ESI数据库对近5年来国内作者高被引临床医学论文情况进行调查与分析,了解我国临床医学类高被引论文的发表情况。方法检索2013—2017年ESI数据库国内高被引论文,分析其地区分布、引用频次、研究机构、研究领域、基金来源、文献类型、期刊分布和主题词等信息。结果共487篇高被引临床医学论文纳入研究,约50%的作者来自上海、北京、江苏和广东;主要分布在全国重点科研院校;2014—2016年每年高被引论文在110篇左右。肿瘤研究是当前国内外医学学者关注的方向。结论我国临床医学研究仍然处于一个不均衡、不协调的发展水平,科研机构应精准把握科研热点,加大科研投入,追踪科研前沿。
Objective To investigate and analyze the highly cited papers of clinical medicine by Chinese authors in recent 5 years based on the ESI database, and to understand the publication condition of highly cited papers of clinical medicine in China. Methods We retrieved the domestic highly-cited papers from the ESI database from 2013 to 2017 by computer, and analyzed the regional distribution, citation frequency, research institutions, research fields, fund sources, paper types, journal distribution and subject terms. Results A total number of 487 highly cited clinical papers were included in the study. About 50% of the authors were from Shanghai, Beijing, Jiangsu and Guangdong province, which mainly distributed in major research institutes nationwide. During the year 2014 to 2016, there were about 110 highly cited papers per year. Cancer research was the main concern to scientists all over the world. Conclusions The clinical research in China is still at an unbalanced and uncoordinated level of development. Research institutions should grasp the hot spots of scientific research, increase research invest, track scientific research frontiers and expand their influence.
作者
董敏
刘雪梅
Dong Min;Liu Xuemei(Editorial Department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery,West China Medical Publishers,West China Hospital,Sichuan University,Chengdu 610041,China)
出处
《中华医学科研管理杂志》
2019年第4期298-302,共5页
Chinese Journal of Medical Science Research Management
关键词
关键词ESI数据库
国内高被引论文
临床医学
Essential Science Indicators database
Chinese highly cited papers
Clinical medicine
